Prognostic outcomes and safety in patients treated with pembrolizumab for advanced urothelial carcinoma: experience in real-world clinical practice
Daichi Tamura, Noriaki Jinnouchi, Masakazu Abé, Daiki Ikarashi, Tomohiko Matsuura, Renpei Kato, Shigekatsu Maekawa, Yoichiro Kato, Mitsugu Kanehira, Ryo Takata, Wataru Obara
Topics & Concepts
MedicinePembrolizumabInternal medicineOncologySurgical oncologyMetastatic Urothelial CarcinomaNeutrophil to lymphocyte ratioMultivariate analysisUnivariate analysisPerformance statusCancerBladder cancerLymphocyteUrothelial carcinomaImmunotherapyBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis